Aortic valve disease constitutes a chronic and progressive disease over time. Age related or degenerative valvular heart disease represents the most common aortic stenosis in the elderly population. It affects more than 25% of patients aged over 65 years.1 TAVI/TAVR (Transcatheter Aortic Valve Implantation/Replacement) has been established as a non-surgical, minimally invasive approach for aortic stenosis in patients of all risk categories. It comprises 12.5% of all aortic valve replacements worldwide.2 Based on clinical evidence, various guidelines are providing new recommendations to diagnose and manage valvular heart diseases. References: Bhatia, N., Basra, S. S., Skolnick, A. H., & Wenger, N.
K. (2016). Aortic valve disease in the older adult. Journal of geriatric cardiology: JGC, 13(12), 941–944. Spears J, Al-Saiegh Y, Goldberg D, Manthey S, Goldberg S. TAVR: A Review of Current…